IL1B and colitis: [131] reported that DI protected against colitis-associated colorectal cancer by inhibiting the IL-1β secretion and macrophages infiltration into the tumor microenvironment, thereby alleviating the high inflammatory state of colitis and reducing the risk of colitis-associated colorectal cancer development.